Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-april-2024
New recommendations to strengthen supply chains of critical medicines
https://www.ema.europa.eu/en/news/new-recommendations-strengthen-supply-chains-critical-medicines
List of medicines under additional monitoring
https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring
Meeting highlights from the PRAC 8-11 April 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-2024
Clinical Trials Information System Webinar: Last Year of Transition
https://www.ema.europa.eu/en/events/clinical-trials-information-system-webinar-last-year-transition
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-8-11-april-2024
Regulatory information – adjusted fees for applications to EMA from 1 April 2024
https://www.ema.europa.eu/en/news/regulatory-information-adjusted-fees-applications-ema-1-april-2024
Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials – Scientific guideline
https://www.ema.europa.eu/en/guideline-quality-non-clinical-clinical-requirements-investigational-advanced-therapy-medicinal-products-clinical-trials-scientific-guideline
